首页> 外文OA文献 >Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)

【2h】

Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)

机译：与5-氟尿嘧啶/卡铂或高剂量顺铂的疗效与强度调制的放射治疗（IMRT）用于局部先进的头部和颈部癌症（Lahnscc）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lauren Q. Shapiro; Eric J. Sherman; Nadeem Riaz; Jeremy Setton; Lawrence Koutcher; Zhigang Zhang; Weiji Shi; Matthew G. Fury; Suzanne L. Wolden; David G. Pfister; Luc Morris; Nancy Lee;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC) [J] . ShapiroL.Q., ShermanE.J., RiazN., Oral oncology . 2014,第10期

机译：并发西妥昔单抗与5-氟尿嘧啶/卡铂或大剂量顺铂联合强度调制放射治疗（IMRT）对局部晚期头颈癌（LAHNSCC）的疗效
2. Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy [J] . TongC.C.L., LauK.H.V., RiveraM., Oncology reports . 2012,第5期

机译：p16在5-氟尿嘧啶，羟基脲，西妥昔单抗和调强放射治疗的同时治疗局部晚期头颈癌的预后意义
3. Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer [J] . Johnny Kao MD, Eric M. Genden MD, Vishal Gupta MD, Cancer . 2011,第2期

机译：同时进行的5-氟尿嘧啶，羟基脲，西妥昔单抗和超分割强度调制放射治疗局部晚期头颈部癌的2期试验
4. Irradiation adaptation to the tumor activity with the help of Intensity-Modulated Radiation Therapy for head and neck cancers [C] . Kubs F., Aletti P., Wolf D., Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2007

机译：借助强度调节的头部和颈部癌症的强度调节放射疗法照射适应肿瘤活性
5. Development of adaptive dose constraints templates for dose optimization in intensity-modulated radiation therapy (IMRT) treatment planning advanced-stage nasopharyngeal cancer. [D] . Chau, Ming Chun. 2007

机译：自适应剂量约束模板的开发，用于在强度调制放射治疗（IMRT）治疗计划晚期鼻咽癌中优化剂量。
6. Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC) [O] . Lauren Q. Shapiro, Eric J. Sherman, Nadeem Riaz, -1

机译：并发西妥昔单抗与5-氟尿嘧啶/卡铂或大剂量顺铂联合强度调制放射治疗（IMRT）对局部晚期头颈癌（LAHNSCC）的疗效
7. Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin [O] . Satoshi Hamauchi, Tomoya Yokota, Takatsugu Mizumachi, 2019

机译：同时性卡铂或西妥昔单抗加放放疗的安全性和有效性，局部晚期头部和颈部癌症患者不需要与顺铂治疗

Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)

著录项

引文网络

相似文献

相关主题

期刊订阅